Keyword
Quick search:
Content Search
Result Content Outlet Published Research
Result Content Outlet Published Research
1 Is A Rise Imminent For Bristol Myers Squibb Stock? Forbes 2 days ago
2 Bristol Myers wrongfully denied exemption requests to COVID-19 vaccination policy, employees say in lawsuit FiercePharma 3 days ago
3 Cohen Milstein Files Class Action Complaint Against Bristol-Myers Squibb Company Yahoo Finance 1 day ago
4 Bristol Myers Squibb's Applications for Deucravacitinib for the Treatment of Moderate to Severe Plaque Psoriasis Accepted by U.S. Food and Drug Administration and Validated by European Medicines Agency Business Wire 6 days ago
5 FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Bristol-Myers Squibb Company BMY 17 days ago
6 Bristol Myers Squibb Awards “Golden Tickets” to Promising Biotechs for Residencies at LabCentral, Biolabs@NYULangone and MBC BioLabs Business Wire 17 days ago
7 Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move? Motley Fool 29 days ago
8 Bristol Myers Squibb Awards "Golden Tickets" to Promising Biotechs for Residencies at LabCentral, Biolabs@NYULangone and MBC BioLabs Yahoo Finance 17 days ago
9 Bristol is one of the worst performing biopharmas this year. Will 2022 be different? Seeking Alpha 15 hours ago
10 Evotec Reaches Programme Designations in Neuroscience Collaboration with Bristol Myers Squibb BioSpace 25 days ago
11 Bristol Myers Launching Nine New Drugs After Bulking Up Pipeline Bloomberg 19 days ago
12 Compugen Announces Collaboration Expansion with Bristol Myers Squibb alongside $20 Million Equity Investment PRNewswire 24 days ago
13 Bristol Myers Squibb Presents Data from Phase 2 AXIOMATIC-TKR Study Nasdaq 19 days ago
14 Title: Bristol-Myers Squibb Company and Celgene Corporation, In the Matter of (Administrative) marketscreener.com 23 days ago
15 BRISTOL MYERS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company BMY 18 days ago
16 Bristol Myers Squibb Co. stock rises Friday, still underperforms market MarketWatch 23 days ago
17 U.S. FDA extends review of Bristol Myers' heart disease drug Reuters 16 days ago
18 Bristol Myers becomes latest victim of unforgiving NASH as midstage asset shelved FierceBiotech 17 days ago
19 Family of Webster woman murdered two years ago files suit against pharmaceutical giant Boston 25 News 2 days ago
20 Bristol Myers Squibb's Opdivo posts another win in early lung cancer, but debate over treatment approach likely remains FiercePharma 27 days ago
21 Biogen's Spinraza, Fosun-Kite's Yescarta and a controversial Alzheimer's drug: All you need to know about China's new state coverage FiercePharma 2 days ago
22 2 Absurdly Cheap Growth Stocks to Buy in December Motley Fool 2 days ago
23 CLARET ASSET MANAGEMENT Corp B GuruFocus.com 3 days ago
24 High Doses Of Dividend Growth Expected From Pfizer, Eli Lilly, Bristol Myers In December Seeking Alpha 6 days ago
25 FDA Updates for Week of Nov. 29, 2021 Managed Healthcare Executive 22 hours ago
26 5 Warren Buffett Stocks Are Screaming Buys in December Motley Fool 2 days ago
27 Bristol Myers Squibb previews new 'transformation' corporate brand campaign at annual global patients' event FiercePharma 2 months ago
28 Immunology Market to grow at a CAGR of 8.45% by 2025|Insights on Emerging Trends, Opportunities & New Product Launches | 17000+ Technavio Reports Yahoo Finance 5 days ago
29 BRISTOL MYERS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Comp Yahoo Finance 25 days ago
30 Bristol Myers Squibb Stock Remains Undervalued After Positive Data From Clinical Trials Forbes 6 months ago
31 Nektar And Bristol Myers Squibb Expecting Bempeg Approval Seeking Alpha 3 months ago
32 Should You Buy Bristol Myers Squibb Stock At $63? Forbes 8 months ago
33 Fitch Affirms Bristol-Myers Squibb's IDR at 'A-'; Withdraws Ratings; Outlook Revised to Stable Fitch Ratings 6 months ago
34 Bristol-Myers Squibb Pays $75 Million to Resolve False Claims Act Allegations Policy & Medicine 7 months ago
35 Bristol-Myers Squibb Company's (BMY) CEO Giovanni Caforio Presents at Morgan Stanley 19th Annual Global Healthcare Brokers Conference (Transcript) Seeking Alpha 3 months ago
36 State to receive $1.2M in in settlement from Bristol-Myers Squibb News 40 5 months ago
37 Bristol Myers Squibb Announces Dividend Business Wire 3 months ago
38 Bristol Myers will likely settle the $6.4B Celgene CVR lawsuit at a discount, analyst says. Here's why FiercePharma 5 months ago
39 Omicron likely to spread beyond Canada and Brazil, says regional health agency Nasdaq 4 days ago
40 It had to happen: Ex-Celgene shareholders sue Bristol Myers Squibb for $6.4B in lost CVR cash, claiming 'blatant misconduct' FiercePharma 6 months ago
41 BMS Dives into AI Deal with Exscientia that Could Hit $1.2 Billion BioSpace 7 months ago
42 Here's My Top Cryptocurrency to Buy Before the New Year Nasdaq 2 days ago
43 Can Gilead Beat Bristol Myers Squibb With Its Cancer CAR-T Therapy? The Motley Fool 5 months ago
44 Bristol Myers Squibb engaged in Acceleron buyout talks but couldn't justify the price: report FiercePharma 2 months ago
45 Attorney General announces settlement with Bristol-Myers Squibb Kotatv 3 months ago
46 Bristol Myers Squibb Reports First Quarter Financial Results for 2021 Business Wire 7 months ago
47 Bristol-Myers Squibb to Pay $75 Million to Resolve False Claims Act Allegations of Underpayment of Drug Rebates Owed Through Medicaid Department of Justice 8 months ago
48 Bristol Myers Squibb CEO Caforio collected $20M in 2020 pay amid Celgene integration, pandemic challenges FiercePharma 9 months ago
49 Bristol-Myers Stalled Cancer Drug Tied to Celgene Deal, Suit Says (1) Bloomberg Law 2 months ago
50 Bristol Myers Squibb Announces Up to Five Years of Data from Long-Term DAYBREAK Study Reinforcing Efficacy and Safety Profile of Zeposia (ozanimod) in Patients with Relapsing Forms of Multiple Sclerosis Business Wire 2 months ago
51 The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to Be Trained Yahoo Finance 1 month ago
52 Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, Switzerland Business Wire 4 months ago
53 Bristol Myers' $1.2B discovery pact with Exscientia strikes gold as first drug candidate selected FierceBiotech 4 months ago
54 Bristol Myers Squibb Receives European Commission Approval for Abecma (Idecabtagene Vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma Business Wire 4 months ago
55 Bristol Myers Squibb to Highlight More than 80 Abstracts at ASH 2021 Demonstrating Strength of Innovative Therapeutic Platforms Improving Outcomes for a Broad Range of Hematologic Diseases Business Wire 1 month ago
56 Bristol Myers Squibb Provides Update on Phase 2 Study of Deucravacitinib in Patients With Moderate to Severe Ulcerative Colitis Yahoo Finance 2 months ago
57 Bristol-Myers Squibb's New Cell Therapy Manufacturing Facility, Devens pharmaceutical-technology.com 9 months ago
58 Bristol-Myers, Eisai in up to $3.1 bln deal to develop cancer drug candidate Reuters 6 months ago
59 Bristol Myers Squibb Provides Update on Status of Contingent Value Rights Business Wire 11 months ago
60 Bristol-Myers Squibb becomes latest pharma to require employee vaccinations Seeking Alpha 3 months ago
61 More than 230 Bristol Myers Squibb Employees Pedal Across the U.S. to Advance Cancer Research in Seventh Annual Coast 2 Coast 4 Cancer Ride Business Wire 3 months ago
62 Bristol Myers Squibb Announces Earnings Call Time Change; Third Quarter 2021 Earnings Call to Occur on October 27, 2021 at 10 a.m. (Eastern Time) Business Wire 1 month ago
63 Bristol Myers Squibb and Five Leading Historically Black Colleges and Universities Launch Tomorrow's Innovators to Create Custom Biopharma Educational Programming and Increase Recruitment of Black Talent in the Biopharma Industry Howard Newsroom 4 months ago
64 An Accidental Disclosure Exposes a $1 Billion Tax Fight With Bristol Myers The New York Times 8 months ago
65 Bristol Myers Squibb Data at the EADV 30th Anniversary Congress Highlight the Growing Body of Evidence on Deucravacitinib and Scientific Advancements for Patients with Serious Dermatologic Diseases Business Wire 2 months ago
66 Bolt Biotherapeutics, Bristol-Myers Squibb sign cancer immunotherapy deal San Francisco Business Times 3 months ago
67 Bristol Myers Squibb Research at ESMO 2021 Demonstrates Clinical Benefits of Immunotherapies in Multiple Hard-to-Treat Advanced or Metastatic Cancers and Reinforces the Benefit of Opdivo in Earlier-Stage Cancers Business Wire 3 months ago
68 Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus' Anti-TIGIT Bispecific Antibody Program Business Wire 7 months ago
69 Attorney General Bonta Announces $75 Million Nationwide Settlement with Global Pharmaceutical Company Bristol Myers Squibb California Department of Justice 4 months ago
70 Bristol Myers Squibb hires Michelle Weese to lead corporate affairs PR Week 6 months ago
71 Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of Tender Offers for an Aggregate Purchase Price of Up to $4.0 Billion Business Wire 10 months ago
72 Bristol Myers hematology chief Ahmed's out the door amid CAR-T missteps FiercePharma 11 months ago
73 Inspirna Announces Clinical Collaboration with Bristol Myers Squibb to Study RGX-104 in Combination with Yervoy® (ipilimumab) for Treatment of Metastatic Endometrial Cancer BioSpace 1 month ago
74 With Revlimid erosion coming, Bristol Myers spotlights early performance of CAR-Ts Abecma, Breyanzi FiercePharma 1 month ago
75 Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2020 Business Wire 10 months ago
76 Bristol Myers Squibb is nixing BeiGene's Abraxane deal in China amid manufacturing woes. Is their cancer rivalry really to blame? FiercePharma 2 months ago
77 Bristol Myers Squibb Stock Can Offer Better Returns Over Eli Lilly Forbes 10 months ago
78 BMS Flying High in May With Opdivo, Zeposia FDA Approvals BioSpace 6 months ago
79 Bristol Myers Squibb Co. stock outperforms market despite losses on the day MarketWatch 5 months ago
80 Evotec Announces Bristol Myers Squibb Opt-in of EVT8683 as the First Programme from iPSC-based Neurodegeneration Collaboration Yahoo Finance 3 months ago
81 Despite FTC's harsh words for biopharma M&A, Bristol Myers CEO Caforio still enthusiastic about deal-making FiercePharma 7 months ago
82 BRISTOL MYERS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Yahoo Finance 11 days ago
83 Bristol Myers Squibb can grow through Revlimid generics, execs insist, pointing to key launches FiercePharma 10 months ago
84 U.S. Food and Drug Administration Accepts Bristol Myers Squibb's Applications for Opdivo (nivolumab) + Yervoy (ipilimumab) and Opdivo + Chemotherapy for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Business Wire 2 months ago
85 Bristol-Myers Squibb (BMY) Q1 2021 Earnings Call Transcript Motley Fool 7 months ago
86 Bristol Myers Seeks Redeeming Combination for Struggling Checkpoint Inhibitor BioSpace 4 months ago
87 Bristol Myers Squibb to Host Virtual Investor Event to Discuss ASCO 2021 Highlights Business Wire 6 months ago
88 Bristol Myers Squibb, Sanofi to pay $834m in Plavix case Aljazeera.com 10 months ago
89 Bristol Myers Squibb BMY 3 months ago
90 Bristol Myers Squibb wins first CAR-T therapy approval in multiple myeloma MedCity News 8 months ago
91 Bristol Myers Squibb's regulatory missteps on Breyanzi can't all be blamed on COVID: analyst FiercePharma 8 months ago
92 Here's Why Bristol Myers Squibb's Partners Think 2021 Could Be Prosperous Motley Fool 11 months ago
93 We Wouldn't Be Too Quick To Buy Bristol-Myers Squibb Company (NYSE:BMY) Before It Goes Ex-Dividend Nasdaq 2 months ago
94 Is This Leading COVID Stock a Buy Right Now? Motley Fool 5 days ago
95 Bristol Myers hits CAR-T manufacturing bottleneck as Abecma demand outstrips supply FiercePharma 4 months ago
96 SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Bristol-Myers Squibb Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Yahoo Finance 1 month ago
97 Bristol Myers Squibb Data at EULAR 2021 Highlight Commitment to Driving Advancements Across Multiple Immune-Mediated Rheumatic Diseases Business Wire 6 months ago
98 Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma of the Head and Neck Business Wire 5 months ago
99 Bristol Myers Squibb to build new cell therapy manufacturing site in the Netherlands BioPharma-Reporter.com 8 months ago
100 Exelixis Announces Clinical Trial Collaboration and Supply Agreement with Bristol Myers Squibb to Evaluate XL092 in Combination with Immuno-oncology Therapies in Advanced Solid Tumors Business Wire 6 months ago